ACADIA Pharmaceuticals Inc (ACAD)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 81,841 | 45,731 | 10,166 | 19,141 | 20,550 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $81,841K ÷ $—K
= —
The payables turnover ratio for ACADIA Pharmaceuticals Inc seems to be unavailable or not disclosed for the years 2020 to 2024 based on the provided data. The payables turnover ratio is a liquidity metric that measures how efficiently a company manages its accounts payable by evaluating the number of times a company pays off its average accounts payable balance during a specific period. Without specific data points for this ratio, it is challenging to assess the efficiency of ACADIA Pharmaceuticals Inc in managing its supplier obligations and its ability to pay off its debts in a timely manner. Further information or historical trends would be required to provide a more in-depth analysis of the company's payables turnover ratio and its implications for its financial performance.
Peer comparison
Dec 31, 2024